Milestone Pharmaceuticals... (MIST)
NASDAQ: MIST
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.67
-1.47%
After-hours: Aug 15, 2025, 07:57 PM EDT
Milestone Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M | -13.61M | -15.08M | -16.04M | -14.95M | -13.18M | -14.56M | -16.65M | -14.01M | -16.88M | -14.22M | 770K | -12.51M |
Depreciation & Amortization | 27K | 26K | 25K | 26K | 28K | 532K | 24K | 24K | 18K | 15K | 27K | 24K | 23K | 23K | 24K | 23K | 23K |
Stock-Based Compensation | 1.35M | 1.47M | 1.4M | 1.39M | 1.51M | 1.88M | 2.87M | 2.49M | 2.29M | 2.14M | 2.38M | 2.41M | 2.11M | 1.98M | 2.02M | 1.91M | 1.37M |
Other Working Capital | n/a | 3.49M | -805.22K | -115.65K | 806K | 3.78M | -789K | 2.11M | -491K | -1.33M | 404.67K | 269.72K | 60K | 2.51M | 2.79M | -1.69M | -997K |
Other Non-Cash Items | n/a | 873.76K | 1.22M | 1.52M | 4.05M | 6.45M | 842K | 854K | -50K | 44K | 2.83M | 2.71M | 2.33M | 42.85M | 1.51M | 1.88M | 1.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -5.6M | -28K | n/a | n/a | n/a | -2.83M | -2.71M | n/a | -42.85M | n/a | n/a | n/a |
Change in Working Capital | n/a | 3.15M | 208K | 376K | -899K | 1.13M | -789K | 2.11M | -1.22M | -1.89M | 576K | 128K | -2.08M | 2.51M | 2.79M | -1.69M | -1.35M |
Operating Cash Flow | -13.95M | -6.84M | -7.02M | -6.05M | -8.93M | -9.22M | -12.16M | -10.56M | -13.9M | -12.86M | -11.57M | -14.09M | -13.95M | -12.38M | -9.39M | 1.01M | -12.47M |
Capital Expenditures | n/a | -22K | 6.95K | -7K | n/a | -29.64K | -18K | -31K | -32K | -110K | -103K | -59K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -53.87M | 10.84M | 28M | n/a | 16.91M | 16.95M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -13.97M | -29.76M | -17.31M | -52.51M | -39.65M | -25.84M | -55M | -15M | -22.91M | -39.95M | -15M | -8M | 15M | -15M | n/a | n/a |
Sales Maturities Of Investments | 34.47M | 32.95M | 36.62M | 26.8M | 25.5M | 53.35M | 15M | 27M | 45M | 6M | 23M | n/a | n/a | 15M | 38M | 20M | 12M |
Other Investing Acitivies | -883K | -630 | -99.6M | n/a | -52.51M | n/a | -10.84M | -28M | n/a | -16.91M | -16.95M | -15M | -8M | -15M | 23M | 20M | 12M |
Investing Cash Flow | 33.58M | 19.33M | 6.36M | 9.48M | -27.01M | 13.67M | -10.86M | -28.03M | 29.97M | -17.02M | -17.05M | -15.06M | -8M | 15M | 23M | 20M | 12M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 251K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 140K | 24K | 74K | -47K | 4.78M | 1K | 305K | -2.78M | 253K | 227K | 2.67M | 140K | 49K | 92K | 24K | 4.92M | 19K |
Financial Cash Flow | 140K | 24K | 300.61K | -298K | 32.32M | 1K | 305K | -2.77M | 50.25M | 227K | 2.67M | 140K | 49K | 92K | 24K | 4.92M | 19K |
Net Cash Flow | 19.77M | 12.52M | -463K | 3.13M | -3.63M | 3.88M | -22.71M | -41.36M | 66.32M | -29.65M | -25.95M | -29M | -21.9M | 2.71M | 13.63M | 25.93M | -451K |
Free Cash Flow | -13.95M | -6.87M | -7.02M | -6.06M | -8.93M | -9.25M | -12.18M | -10.6M | -13.94M | -12.97M | -11.68M | -14.14M | -13.95M | -12.38M | -9.39M | 1.01M | -12.47M |